BIO Stock Summary and Trading Ideas (Bio-Rad Laboratories Class A | NYSE:BIO)

Bio-Rad Laboratories Inc manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. It operates in two industry segments; In Clinical Diagnostics segment, the company manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In Life Sciences segment, the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with majority of the revenue being generated from United States, it also has its presence in Europe, Asia, Canada and other regions.

Bio-Rad Laboratories Class A trades on the NYSE stock market under the symbol BIO.

As of April 19, 2024, BIO stock price declined to $279.73 with 285,906 million shares trading.

BIO has a beta of 1.91, meaning it tends to be more sensitive to market movements. BIO has a correlation of 0.40 to the broad based SPY ETF.

BIO has a market cap of $7.98 billion. This is considered a Mid Cap stock.

Last quarter Bio-Rad Laboratories Class A reported $681 million in Revenue and $3.10 earnings per share. This fell short of revenue expectation by $-4 million and exceeded earnings estimates by $.28.

In the last 3 years, BIO stock traded as high as $832.70 and as low as $261.59.

The top ETF exchange traded funds that BIO belongs to (by Net Assets): VTI, VOO, VB, VBR, RSP.

BIO has underperformed the market in the last year with a price return of -41.6% while the SPY ETF gained +21.2%. BIO has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -8.0% and -13.4%, respectively, while the SPY returned +4.3% and -3.5%, respectively.

BIO support price is $273.57 and resistance is $288.47 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BIO stock will trade within this expected range on the day.